MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Incyte Corporation - Common Stock (NQ:INCY)

100.86 +2.02 (+2.04%)
Streaming Delayed Price Updated: 3:58 PM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Incyte Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
News headline image
Incyte (INCY) Deep Dive: Navigating the 2026 Crossroads Following Earnings Miss
As of February 11, 2026, Incyte Corporation (NASDAQ: INCY) finds itself at a pivotal crossroads. Known for over a decade as a one-drug powerhouse centered on the hematology blockbuster Jakafi, the... 
Via Finterra
Topics Economy Intellectual Property
News headline image
INCY Q4 Deep Dive: Revenue Growth Outpaces Profit as Pipeline Advances, Margins Narrow
Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) announced better-than-expected revenue in Q4 CY2025, with sales up 27.8% year on year to $1.51 billion. Its non-GAAP profit of $1.80 per share... 
Via StockStory
What's going on in today's session: S&P500 movers ↗
Via Chartmill
Incyte Corp. (NASDAQ:INCY) Reports Mixed Q4 2025 Results with Revenue Beat and EPS Miss ↗
Via Chartmill
Value Investing Opportunity: Incyte Corp. (NASDAQ:INCY) Presents a Compelling Case ↗
Via Chartmill
Incyte Corp. (NASDAQ:INCY) Emerges as a Compelling Value Stock with Strong Fundamentals ↗
Via Chartmill
Stay informed with the top movers within the S&P500 index on Tuesday. ↗
Via Chartmill
News headline image
Why Incyte (INCY) Stock Is Nosediving
Shares of biopharmaceutical company Incyte Corporation (NASDAQ:INCY) fell 8.8% in the morning session after the company reported mixed fourth-quarter 2025 results, where a significant revenue beat was... 
Via StockStory
Topics Artificial Intelligence Earnings
Which S&P500 stocks are gapping on Tuesday? ↗
Via Chartmill
News headline image
Incyte (INCY) Q4 2025 Earnings Call Transcript ↗
Incyte (INCY) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Which S&P500 stocks are moving before the opening bell on Tuesday? ↗
Via Chartmill
News headline image
Incyte (NASDAQ:INCY) Surprises With Q4 CY2025 Sales
Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 27.8% year on year to $1.51 billion. Its non-GAAP profit of... 
Via StockStory
Topics Artificial Intelligence
News headline image
Incyte Reports Fourth Quarter and Full Year 2025 Financial Results
From Incyte
Via Business Wire
News headline image
Incyte (INCY) Q4 Earnings: What To Expect
Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) will be announcing earnings results this Tuesday before market open. Here’s what to look for. 
Via StockStory
Topics World Trade
News headline image
Incyte to Report Fourth Quarter and Year-End 2025 Financial Results
From Incyte
Via Business Wire
News headline image
2 Profitable Stocks Worth Investigating and 1 We Turn Down
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
Which S&P500 stocks are moving on Friday? ↗
Via Chartmill
Friday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
2 Value Stocks Worth Investigating and 1 That Underwhelm
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful... 
Via StockStory
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Via Chartmill
News headline image
3 Value Stocks Worth Investigating
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are... 
Via StockStory
Topics Credit Cards
News headline image
2 Mid-Cap Stocks with Exciting Potential and 1 We Question
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract... 
Via StockStory
News headline image
Why Incyte (INCY) Stock Is Trading Up Today
Shares of biopharmaceutical company Incyte Corporation (NASDAQ:INCY) jumped 3.2% in the afternoon session after TD Cowen maintained a 'Buy' rating on the stock and increased its price target. The... 
Via StockStory
Topics Artificial Intelligence
What's going on in today's session: S&P500 movers ↗
Via Chartmill
News headline image
Rule Breaker Investing Market Cap Game Show: Is Your Favorite Stock in the Spotlight? ↗
It's time once again for the Market Cap Game Show Holiday Edition, where intuition meets valuation and everyday life meets market caps. 
Via The Motley Fool
News headline image
2 Cash-Heavy Stocks Worth Investigating and 1 Facing Challenges
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory
These S&P500 stocks are moving in today's session ↗
Via Chartmill
Discover which S&P500 stocks are making waves on Wednesday. ↗
Via Chartmill
News headline image
Incyte (INCY) Stock Is Up, What You Need To Know
Shares of biopharmaceutical company Incyte Corporation (NASDAQ:INCY) jumped 3.7% in the morning session after the company announced positive top-line results from a late-stage study of its lymphoma... 
Via StockStory
Topics Artificial Intelligence
News headline image
Incyte Announces Positive Topline Results from Pivotal Study of Tafasitamab (Monjuvi®/Minjuvi®) as a First-line Treatment for Diffuse Large B-Cell Lymphoma
From Incyte
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story